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Hypertension continues to be the leading cause of death and disability in the indus-
trialized world, with a high level of unawareness and unacceptably poor control.
Therefore, the Argentinian Society of Hypertension, in agreement with the May
Measurement Month (MMM) initiative of the International Society of Hypertension,
implemented for the second consecutive year an educational campaign during the
month of May 2018. A volunteer cross-sectional survey was carried out in public
spaces and health centres during the month of May 2018 across 33 cities in
Argentina. Hypertension was defined as systolic blood pressure (BP) 140mmHg or
diastolic BP 90mmHg based on the mean of the 2nd and 3rd of three consecutive
BP measurements, or in those on treatment for high BP. Statistical analysis including
multiple imputation followed the MMM protocol. A total of 70 418 individuals were
screened during MMM18, after excluding those under 18 years old. Of the total,
43.8% of participants were classified as hypertensive, 77.7% were aware of their di-
agnosis, 69.1% were on pharmacological treatment, and 38.7% were controlled. Of
those on antihypertensive medication, 56.0% were controlled. It is necessary to rein-
force strategies not only to increase the awareness and control of hypertension but
also to identify the population groups, in which these strategies would have the
greatest impact, helping to reduce the enormous health burden attributed to
hypertension.
Introduction
Hypertension represents the leading cause of death and
disability in the industrialized world,1 even though its phar-
macological treatment has been repeatedly proven to ef-
fectively reducemorbidity andmortality.2,3
Argentina, with a population of more than 40 million
people, does not escape from this problem, with 40% of
the global mortality attributable to cardiovascular dis-
eases.4 The prevalence of hypertension in our country is ap-
proximately 33–36%5 and making things even worse is that
this main risk factor for morbidity and mortality has a high
level of unawareness and very low degree of control among
the population.6,7 With this background, the Argentinian
Society of Hypertension (SAHA) has, among its main objec-
tives, the design and establishment of different strategies
intended to improve the degree of knowledge and control
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of hypertension in our country. In the last screening cam-
paign performed in Argentina during May 2017,8 it was
detected that 6 out of 10 hypertensive patients were either
not on treatment or did not reach the blood pressure (BP)
goal values.
Thus, we believe that educational campaigns will be a
useful tool to increase the knowledge and awareness of
this highly prevalent cardiovascular problem, hopefully
leading to a reduction in the enormous health burden at-
tributed to high BP. In 2018, during the month of May and
similar to the previous year, SAHA actively participated in a
synchronized and standardized multinational screening
campaign of hypertension proposed by the International
Society for Hypertension and endorsed by the World
Hypertension League named ‘May Measurement Month’
(MMM18).9 The Argentinian programmewas dubbed: ‘Know
and control your blood pressure’.
Methods
SAHA invited all its associates to participate in the multina-
tional campaign to measure BP in the general population.
All of the individuals screened agreed to participate of
their own freewill.
The campaign, co-ordinated by 60 SAHA members, was
mainly conducted at hospitals and health centres, although
some public spaces and pharmacies were also included. It
took place in 33 cities in Argentina, representing 15 out of
the 23 country states. At the participating centres, art-
works and banners announced the campaign and brochures
were supplied to the public.
Screened volunteers were asked a few questions to
gather additional data and their BP was measured two, or
ideally three times, with 1-min intervals between readings,
on the left arm (preferably) in a seated position. Omron
and Microlife validated automatic devices were used. This
information was entered via Google form or, alternatively,
manually on a spread sheet.
Multiple imputation based on the global data9 was used
to impute the mean of the 2nd and 3rd BP readings. Blood
pressure was calculated as the mean of the 2nd and 3rd
readings, and hypertension was defined as systolic BP
140mmHg or diastolic BP90mmHg or in those on treat-
ment for high BP. Among those treated, controlled BP was
defined with values of <140/90mmHg. Weight and height
were self-reported and body mass index (BMI) was calcu-
lated. Those participants classified as hypertensive were
provided with visual material detailing dietary and lifestyle
advice to lower their BP.
Continuous variables (age, BMI, systolic BP, and diastolic
BP) were expressed as mean 6 standard deviation. Data
were analysed centrally using Stata and P-values <0.05
(two-tailed) were considered statistically significant.
Results
A total of 70 418 individuals had their BP measured during
the month of May 2018 in the context of the MMM initiative
by the Argentinian ‘Know and control your blood pressure’
local campaign. Of those screened, mean age was
54.66 17.8years, mean BMI was 28.16 5.3 kg/m2, 58%
were women, and 30.3% were currently on antihyperten-
sivemedication.
The prevalence of hypertension was 43.8%. Of those with
hypertension, 77.7% were aware, 69.1% were on medica-
tion, and 38.7% were controlled. Of those on medication,
56.0% were controlled. Furthermore, 19.4% of those not
on any antihypertensive medication were found with
raised BP.
Based on linear regression models, adjusted for age and
sex (with an interaction) and antihypertensive medication,
overweight, and obese participants were associated with
higher systolic and diastolic BPs compared to participants
with healthy weights. Conversely, underweight vs. healthy
weight participants were associated with lower systolic
and diastolic BPs (Supplementary material online,
Figure S1).
Discussion
The screening campaign performed in Argentina with the
slogan ‘Know and control your blood pressure’ as part of
the international MMM18, doubled the number of people
surveyed compared with the previous year. Among the
most relevant results of the 2018 edition is the persistence
of a high proportion of hypertensive individuals. The over-
all prevalence of hypertension (43.8%) was lower than
that found in MMM17 (50.4%) and other studies in our
country.8,10
The level of awareness among individuals with hyperten-
sion is high (77.7%). However, the level of control of BP
amongst those on medication, was poor and insufficient,
with almost half uncontrolled, similar at previous edition
of this same campaign. Therefore, it is clear that we have
not improved in this persisting as a critical health problem
in our country.
Thus, the low level of control of hypertension generates
the critical need for the development of community-based
prevention strategies (primary prevention). Interestingly,
in a previous population-based study in our country, it was
found that the ‘healthier’ individuals (lower BP values and
rates of adiposity at time of the study) develop to greater
weight gain and increases in BP which doubled the risk of
cardiovascular diseases 10years after the onset of a health
programme.11
Therefore, campaigns such as MMM18 not only emerge as
necessary strategies to increase the awareness on this
highly prevalent cardiovascular disease but also to identify
the population groups in which these strategies would have
the greatest impact, helping to reduce the enormous
health burden attributed to hypertension.
Supplementary material
Supplementary material is available at European Heart
Journal Supplements online.
Acknowledgements
The authors thank all volunteer SAHA staff and all the par-
ticipants: F. Garcia Vasquez, P. Becerra, C. Ressina, N.









11/5898733 by guest on 01 Septem
ber 2020
Soraya, N. Burgos, R. Simsolo, C. Laspiur, P. Grosse, E.
Marissi, A. Diaz, M.J. Castro, C. Romero, M. Del Sueldo, P.
Irusta, D. Cianfagna, A. De Cerchio, A. Kalbermatter, A.
Herrera, M. Gonzalez, G. Brusca, A. Iturzaeta, M.G. Ruisse,
P. Berton, A. Lagos, G. Stafieri, G. Caruso, A. Corrales
Barboza, L. Pompozzi, P. Rumi, C. Castellaro, G. Vives, M.
Cavallo, J. Romano, G. Lavenia, J. Menendez, F. Risso
Patron, L. Ghezzi, D. Fernandez, P. Carrizo, K. Palacios, S.
Vissani, C. Kotliar, R. Sabio, J. Serra, P. Rodriguez, A.
Christen, A. Stratta, D. Llanos, N. Renna, and J. Caputo
Westberg.
Conflict of interest: none declared.
References
1. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L,
Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-
Guzman N, Azzopardi P, Banerjee A, Bärnighausen T, Basu A, Bekele
T, Bennett DA, Biadgilign S, Catalá-López F, Feigin VL, Fernandes JC,
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